Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Mini Reviews in Medicinal Chemistry
|
October 8, 2003
Extending chemoselective ligation to sugar chemistry: convergent assembly of bioactive neoglycoconjugates
Francesco Peri
Chemical Society Reviews
|
December 20, 2012
Clustered carbohydrates in synthetic vaccines
Francesco Peri
Biotechnology Advances
|
June 14, 2011
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
Francesco Peri, Matteo Piazza
Future Medicinal Chemistry
|
January 31, 2018
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives
Lenny Zaffaroni, Francesco Peri
Chemical Communications (Cambridge, England)
|
March 11, 2004
Chemoselective ligation in glycochemistry
Francesco Peri, Francesco Nicotra
International Journal of Molecular Sciences
|
November 4, 2017
The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling
Florent Cochet, Francesco Peri
Frontiers in Immunology
|
August 9, 2020
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
Alessio Romerio, Francesco Peri
Journal of Medicinal Chemistry
|
November 6, 2013
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update
Francesco Peri, Valentina Calabrese
Frontiers in Chemistry
|
November 29, 2023
Cleaner synthesis of preclinically validated vaccine adjuvants
Alessio Romerio, Francesco Peri
Cells
|
January 20, 2021
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
Ana Rita Franco, Francesco Peri
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Mini Reviews in Medicinal Chemistry
|
October 8, 2003
Extending chemoselective ligation to sugar chemistry: convergent assembly of bioactive neoglycoconjugates
Francesco Peri
Chemical Society Reviews
|
December 20, 2012
Clustered carbohydrates in synthetic vaccines
Francesco Peri
Biotechnology Advances
|
June 14, 2011
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
Francesco Peri, Matteo Piazza
Future Medicinal Chemistry
|
January 31, 2018
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives
Lenny Zaffaroni, Francesco Peri
Chemical Communications (Cambridge, England)
|
March 11, 2004
Chemoselective ligation in glycochemistry
Francesco Peri, Francesco Nicotra
International Journal of Molecular Sciences
|
November 4, 2017
The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling
Florent Cochet, Francesco Peri
Frontiers in Immunology
|
August 9, 2020
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
Alessio Romerio, Francesco Peri
Journal of Medicinal Chemistry
|
November 6, 2013
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update
Francesco Peri, Valentina Calabrese
Frontiers in Chemistry
|
November 29, 2023
Cleaner synthesis of preclinically validated vaccine adjuvants
Alessio Romerio, Francesco Peri
Cells
|
January 20, 2021
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
Ana Rita Franco, Francesco Peri
Page
of 10